HEADER DNA BINDING PROTEIN/INHIBITOR 20-AUG-15 5AYG TITLE CRYSTAL STRUCTURE OF THE HUMAN ROR GAMMA LIGAND BINDING DOMAIN WITH 3G COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 261-518; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, NUCLEAR RECEPTOR, DNA BINDING PROTEIN-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.NOGUCHI,S.DOI,A.NOMURA,M.KIKUWAKA,K.MURASE,K.HIRATA,M.KAMADA, AUTHOR 2 T.ADACHI REVDAT 3 08-NOV-23 5AYG 1 REMARK REVDAT 2 26-FEB-20 5AYG 1 REMARK REVDAT 1 02-MAR-16 5AYG 0 JRNL AUTH K.HIRATA,M.KOTOKU,N.SEKI,T.MAEBA,K.MAEDA,S.HIRASHIMA, JRNL AUTH 2 T.SAKAI,S.OBIKA,A.HORI,Y.HASE,T.YAMAGUCHI,Y.KATSUDA,T.HATA, JRNL AUTH 3 N.MIYAGAWA,K.ARITA,Y.NOMURA,K.ASAHINA,Y.ARATSU,M.KAMADA, JRNL AUTH 4 T.ADACHI,M.NOGUCHI,S.DOI,P.CROWE,E.BRADLEY,R.STEENSMA,H.TAO, JRNL AUTH 5 M.FENN,R.BABINE,X.LI,S.THACHER,H.HASHIMOTO,M.SHIOZAKI JRNL TITL SAR EXPLORATION GUIDED BY LE AND FSP(3): DISCOVERY OF A JRNL TITL 2 SELECTIVE AND ORALLY EFFICACIOUS ROR GAMMA INHIBITOR JRNL REF ACS MED.CHEM.LETT. V. 7 23 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 26819660 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00253 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0107 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 85.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20852 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1128 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1515 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.11000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : 0.36000 REMARK 3 B12 (A**2) : -0.05000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.374 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.252 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.347 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3654 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4916 ; 2.052 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 436 ; 6.714 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 175 ;32.808 ;23.143 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 666 ;16.690 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;23.633 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 536 ; 0.157 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2727 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1747 ; 5.493 ; 5.486 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2182 ; 7.792 ; 8.212 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1907 ; 7.899 ; 5.775 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 14897 ;12.440 ;50.842 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SF FILE CONTAINS FRIEDEL PAIRS UNDER REMARK 3 I/F_MINUS AND I/F_PLUS COLUMNS. REMARK 4 REMARK 4 5AYG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1300000195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22021 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 85.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.60 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3BOW REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN F_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL , PH 7.5, 0.5M NA/K REMARK 280 TARTRATE, 2.5M, MPD, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.61333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 85.22667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 63.92000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 106.53333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.30667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 261 REMARK 465 ALA A 262 REMARK 465 PRO A 263 REMARK 465 GLU A 481 REMARK 465 ARG A 482 REMARK 465 LEU A 483 REMARK 465 GLN A 484 REMARK 465 ILE A 485 REMARK 465 PHE A 486 REMARK 465 GLN A 487 REMARK 465 HIS A 488 REMARK 465 LEU A 489 REMARK 465 HIS A 490 REMARK 465 PRO A 491 REMARK 465 ILE A 492 REMARK 465 VAL A 493 REMARK 465 VAL A 494 REMARK 465 GLN A 495 REMARK 465 ALA A 496 REMARK 465 ALA A 497 REMARK 465 PHE A 498 REMARK 465 PRO A 499 REMARK 465 PRO A 500 REMARK 465 LEU A 501 REMARK 465 TYR A 502 REMARK 465 LYS A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 THR A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 PRO A 513 REMARK 465 VAL A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 SER A 517 REMARK 465 LYS A 518 REMARK 465 GLU B 261 REMARK 465 ALA B 262 REMARK 465 PRO B 263 REMARK 465 LEU B 483 REMARK 465 GLN B 484 REMARK 465 ILE B 485 REMARK 465 PHE B 486 REMARK 465 GLN B 487 REMARK 465 HIS B 488 REMARK 465 LEU B 489 REMARK 465 HIS B 490 REMARK 465 PRO B 491 REMARK 465 ILE B 492 REMARK 465 VAL B 493 REMARK 465 VAL B 494 REMARK 465 GLN B 495 REMARK 465 ALA B 496 REMARK 465 ALA B 497 REMARK 465 PHE B 498 REMARK 465 PRO B 499 REMARK 465 PRO B 500 REMARK 465 LEU B 501 REMARK 465 TYR B 502 REMARK 465 LYS B 503 REMARK 465 GLU B 504 REMARK 465 LEU B 505 REMARK 465 PHE B 506 REMARK 465 SER B 507 REMARK 465 THR B 508 REMARK 465 GLU B 509 REMARK 465 THR B 510 REMARK 465 GLU B 511 REMARK 465 SER B 512 REMARK 465 PRO B 513 REMARK 465 VAL B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 SER B 517 REMARK 465 LYS B 518 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 264 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 437 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 478 CG CD OE1 NE2 REMARK 470 HIS A 479 CG ND1 CD2 CE1 NE2 REMARK 470 VAL A 480 CG1 CG2 REMARK 470 TYR B 264 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 HIS B 479 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 481 CG CD OE1 OE2 REMARK 470 ARG B 482 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 288 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 296 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A 296 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 CYS A 345 CA - C - N ANGL. DEV. = 14.5 DEGREES REMARK 500 CYS A 345 O - C - N ANGL. DEV. = -15.2 DEGREES REMARK 500 ASN A 347 C - N - CA ANGL. DEV. = -15.8 DEGREES REMARK 500 ARG A 364 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 282 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B 294 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG B 364 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 367 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 374 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG B 430 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG B 430 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -57.46 81.62 REMARK 500 GLU A 435 54.47 -105.68 REMARK 500 GLN B 286 -62.07 73.70 REMARK 500 GLU B 386 -34.22 -39.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LQ A 9000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LQ B 9000 DBREF 5AYG A 261 518 UNP P51449 RORG_HUMAN 261 518 DBREF 5AYG B 261 518 UNP P51449 RORG_HUMAN 261 518 SEQRES 1 A 258 GLU ALA PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU SEQRES 2 A 258 VAL GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN SEQRES 3 A 258 LEU ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE SEQRES 4 A 258 PHE SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER SEQRES 5 A 258 MET TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR SEQRES 6 A 258 GLU ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SEQRES 7 A 258 SER GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL SEQRES 8 A 258 LEU LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG SEQRES 9 A 258 MET CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE SEQRES 10 A 258 PHE GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA SEQRES 11 A 258 LEU GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SEQRES 12 A 258 SER HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU SEQRES 13 A 258 ILE ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS SEQRES 14 A 258 ARG PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU SEQRES 15 A 258 GLN TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU CYS SEQRES 16 A 258 LYS THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO SEQRES 17 A 258 LYS GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU SEQRES 18 A 258 ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL SEQRES 19 A 258 GLN ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER SEQRES 20 A 258 THR GLU THR GLU SER PRO VAL GLY LEU SER LYS SEQRES 1 B 258 GLU ALA PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU SEQRES 2 B 258 VAL GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN SEQRES 3 B 258 LEU ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE SEQRES 4 B 258 PHE SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER SEQRES 5 B 258 MET TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR SEQRES 6 B 258 GLU ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SEQRES 7 B 258 SER GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL SEQRES 8 B 258 LEU LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG SEQRES 9 B 258 MET CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE SEQRES 10 B 258 PHE GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA SEQRES 11 B 258 LEU GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SEQRES 12 B 258 SER HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU SEQRES 13 B 258 ILE ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS SEQRES 14 B 258 ARG PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU SEQRES 15 B 258 GLN TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU CYS SEQRES 16 B 258 LYS THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO SEQRES 17 B 258 LYS GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU SEQRES 18 B 258 ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL SEQRES 19 B 258 GLN ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER SEQRES 20 B 258 THR GLU THR GLU SER PRO VAL GLY LEU SER LYS HET 4LQ A9000 30 HET 4LQ B9000 30 HETNAM 4LQ 3-[5-(2-CYCLOHEXYLETHYL)-4-ETHYL-1,2,4-TRIAZOL-3-YL]-N- HETNAM 2 4LQ NAPHTHALEN-1-YL-PROPANAMIDE FORMUL 3 4LQ 2(C25 H32 N4 O) FORMUL 5 HOH *85(H2 O) HELIX 1 AA1 SER A 266 CYS A 285 1 20 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 ARG A 310 1 10 HELIX 5 AA5 SER A 312 ARG A 337 1 26 HELIX 6 AA6 CYS A 345 CYS A 366 1 22 HELIX 7 AA7 GLY A 384 GLY A 392 5 9 HELIX 8 AA8 CYS A 393 ALA A 409 1 17 HELIX 9 AA9 SER A 413 ILE A 426 1 14 HELIX 10 AB1 GLU A 435 THR A 457 1 23 HELIX 11 AB2 ARG A 459 LEU A 466 5 8 HELIX 12 AB3 PRO A 468 VAL A 480 1 13 HELIX 13 AB4 SER B 266 CYS B 285 1 20 HELIX 14 AB5 ARG B 288 GLN B 295 1 8 HELIX 15 AB6 ARG B 296 ASN B 298 5 3 HELIX 16 AB7 SER B 301 ARG B 310 1 10 HELIX 17 AB8 SER B 312 ARG B 337 1 26 HELIX 18 AB9 CYS B 345 CYS B 366 1 22 HELIX 19 AC1 GLY B 384 GLY B 392 5 9 HELIX 20 AC2 CYS B 393 ALA B 409 1 17 HELIX 21 AC3 SER B 413 ILE B 426 1 14 HELIX 22 AC4 GLU B 435 THR B 457 1 23 HELIX 23 AC5 ARG B 459 LYS B 465 5 7 HELIX 24 AC6 GLY B 470 ARG B 482 1 13 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O GLY A 383 N VAL A 376 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SITE 1 AC1 10 HIS A 323 LEU A 324 MET A 365 ALA A 368 SITE 2 AC1 10 VAL A 376 PHE A 377 PHE A 378 PHE A 388 SITE 3 AC1 10 PHE A 401 HOH A9123 SITE 1 AC2 13 HIS B 323 LEU B 324 ALA B 327 MET B 365 SITE 2 AC2 13 ALA B 368 VAL B 376 PHE B 377 PHE B 378 SITE 3 AC2 13 PHE B 388 ILE B 400 PHE B 401 HOH B9118 SITE 4 AC2 13 HOH B9124 CRYST1 99.240 99.240 127.840 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010077 0.005818 0.000000 0.00000 SCALE2 0.000000 0.011635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007822 0.00000